REVB short interest
Revelation Biosciences Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 1,581 |
|---|---|
| Change vs prior report | 1,325 (+517.6%) |
| Change over six months | -97.1% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 36,220 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
REVB short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 1,581 | +517.6% | 1.00 | 36,220 |
| 2026-09-15 | 256 | -56.0% | 1.00 | 14,833 |
| 2026-08-31 | 582 | -96.2% | 1.00 | 61,763 |
| 2026-08-14 | 15,394 | -25.7% | 1.00 | 21,146 |
| 2026-07-31 | 20,729 | +2.6% | 1.00 | 40,934 |
| 2026-07-15 | 20,200 | +44.9% | 1.00 | 58,166 |
| 2026-06-30 | 13,941 | -25.2% | 1.00 | 38,868 |
| 2026-06-15 | 18,630 | -29.0% | 1.00 | 50,599 |
| 2026-05-29 | 26,240 | -24.0% | 1.00 | 33,045 |
| 2026-05-15 | 34,510 | +87.5% | 1.00 | 81,197 |
| 2026-04-30 | 18,409 | -18.2% | 1.00 | 89,443 |
| 2026-04-15 | 22,511 | -59.0% | 1.00 | 66,278 |
| 2026-03-31 | 54,960 | +108.1% | 1.00 | 75,363 |
| 2026-03-13 | 26,405 | +102.6% | 1.00 | 79,912 |
| 2026-02-27 | 13,032 | -87.0% | 1.00 | 107,656 |
| 2026-02-13 | 100,079 | -61.2% | 1.00 | 372,176 |
| 2026-01-30 | 258,211 | +845.6% | 1.00 | 3,296,084 |
| 2026-01-15 | 27,307 | -25.6% | 1.00 | 95,930 |
| 2025-12-31 | 36,688 | +25.9% | 1.00 | 94,355 |
| 2025-12-15 | 29,141 | +183.7% | 1.00 | 122,940 |
| 2025-11-28 | 10,272 | +413.3% | 1.00 | 101,382 |
| 2025-11-14 | 2,001 | -93.2% | 1.00 | 147,605 |
| 2025-10-31 | 29,563 | -61.7% | 1.00 | 113,166 |
| 2025-10-15 | 77,245 | +15.7% | 1.00 | 247,386 |
| 2025-09-30 | 66,774 | -37.7% | 1.00 | 278,881 |
import finzdata as yf
yf.Ticker("REVB").short_interest # every report since 2017
yf.Client().short_interest(["REVB"], start="2018-01-01")Healthcare short interest · REVB price history · Who owns REVB · All short interest